Loading organizations...
§ Private Profile · Berlin, Germany
Biotech company creating whole-cut plant-based meat alternatives using mycelium fermentation for meat eaters and flexitarians.
Based in Berlin, Germany, Bosque Foods is a biotechnology company that utilizes solid-state mycelium fermentation to develop whole-cut, plant-based meat alternatives such as chicken cutlets and steaks. The enterprise engineers nutrient-dense protein products designed to accurately replicate the texture and taste of traditional animal meat without relying on extensive industrial processing, artificial ingredients, or synthetic additives. Targeting a projected $9 billion global market for whole-cut alternative meats, the venture has successfully secured $3.22 million in total funding through various equity rounds and convertible notes. Bosque Foods has received financial backing and strategic development support from several prominent institutional investors and specialized accelerator programs, specifically including SOSV, IndieBio, and the ProVeg Incubator. Originally operating under the corporate name Kinoko Labs, the food technology company was founded in 2020 by Isabella Iglesias-Musachio, Maxence Damarey, and Sugriv Gupts.
Bosque Foods has raised $3.0M across 1 funding round.
Bosque Foods has raised $3.0M in total across 1 funding round.
Bosque Foods has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2022 | $3M Seed | — | SOSV, Arman Anatürk, Blue Horizon, Blue Impact, Christian Guba, Happiness Capital | Announced |
Bosque Foods has raised $3.0M in total across 1 funding round.
Bosque Foods's investors include SOSV, Arman Anatürk, Blue Horizon, Blue Impact, Christian Guba, Happiness Capital.
Bosque Foods is a food technology company developing sustainable, mycelium-based whole-cut meat alternatives that mimic the taste, texture, and nutrition of traditional meats like pork and chicken fillets.[1][2][5] These nutrient-dense, minimally processed products target meat eaters seeking plant-based options without additives, addressing environmental issues like high carbon footprints from animal agriculture while serving flexitarians, vegetarians, and vegans through versatile cuts for salads, stir-fries, roasts, and sandwiches.[2][3][5] The company solves the gap in current meat alternatives—mostly burgers and nuggets—by offering clean-label, high-protein, low-fat whole-muscle products via solid-state fermentation, with backing from accelerators like SOSV, ProVeg Incubator, and IndieBio.[2][3][7]
Founded in 2020 as Kinoko Labs in Berlin, Germany (with operations also in New York), Bosque Foods emerged from CEO and Founder Isabella Iglesias-Musachio's lifelong fascination with fungi and fermentation.[1][3][5] Isabella's background spans sustainable agriculture NGOs, nonprofits, and the tech industry, where she identified food systems' role in climate change and envisioned mycelium as a solution for omnivore-friendly alternatives.[5][7] A pivotal moment came through IndieBio's accelerator, where the team showcased prototypes at demo days, leading to rebranding and investor tastings at ProVeg Incubator in Berlin to demonstrate alt-pork and alt-chicken fillets.[3][7] Early traction built on scientific advisors like Branden Wolner and consultants Pedro Gonçalves and Rafael Philippini, evolving from Kinoko Labs to focus on scalable, solid-state mycelium production.[1][5]
Bosque Foods rides the alternative protein wave, specifically mycelium tech, amid rising demand for sustainable foods as animal agriculture drives 14.5% of global emissions.[2][7] Timing aligns with foodtech maturation—fermentation innovations like solid-state methods lower costs and improve texture, filling the "whole-cut" market gap underserved by burgers/nuggets.[1][4][6] Favorable forces include consumer shifts to flexitarian diets, GLP-1-driven health focus, and investor interest via climate tech summits and accelerators like SOSV.[2][7] It influences the ecosystem by accelerating mycelium adoption, inspiring upcycling and precision fermentation, and proving fungi can disrupt culinary traditions without alienating omnivores.[5][6][7]
Bosque Foods is primed for commercial launch and scaling, with prototypes advancing to market penetration via retail, D2C, and partnerships, leveraging its ProVeg and IndieBio momentum.[3][6][7] Trends like mycelium's cost-efficiency, regulatory nods for novel proteins, and "healthspan" nutrition will propel growth, potentially capturing share in a $30B+ alt-protein market.[1][6] Influence may evolve by standardizing whole-muscle fungi products, fostering a delicious, animal-free food system that sways meat eaters—one mycelium filet at a time, fulfilling its zero-compromise promise.[2][5]